When we monitored NFE2L1 and NDUFA9 protein levels using six paired HCC and adjacent tissue samples, four cases showed clearly increased NFE2L1 expression in tumor compared to the surrounding tissue. The gene discussed is NFE2L1; the disease is hepatocellular carcinoma.